Smart Bear Implementation Guide
3.2.2 - ci-build
Smart Bear Implementation Guide - Local Development build (v3.2.2). See the Directory of published versions
| Official URL: https://smart-bear.eu/fhir/ValueSet/LNCVS | Version: 3.2.2 | |||
| Active as of 2022-07-03 | Computable Name: LNCVS | |||
Value set including all codes from LOINC
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://loinc.org
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
Expansion based on Loinc v2.72
All codes in this table are from the system http://loinc.org
| Code | Display |
| 1-8 | Acyclovir [Susceptibility] |
| 10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer |
| 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
| 10000-8 | R wave duration in lead AVR |
| 100002-5 | Specimen care is maintained |
| 100003-3 | Team communication is maintained throughout care |
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure |
| 100005-8 | Demonstrates knowledge of nutritional management related to the procedure |
| 100006-6 | Demonstrates knowledge of medication management |
| 100007-4 | Demonstrates knowledge of pain management |
| 100008-2 | Demonstrates knowledge of wound management |
| 100009-0 | Demonstrates knowledge of the procedure and expected results |
| 10001-6 | R wave duration in lead I |
| 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation |
| 100011-6 | No injury related to an electrical source |
| 100012-4 | Participates in decisions affecting the patient's plan of care |
| 100013-2 | Participates in the discharge process |
| 100014-0 | Psychosocial health is maintained at or improved from baseline |
| 100015-7 | No injury related to positioning due to care or procedure |
| 100016-5 | No injury related to a laser source |
| 100017-3 | Perioperative nursing data set outcomes panel [PNDS] |
| 100018-1 | Hospice care Note |
| 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 10002-4 | R wave duration in lead II |
| 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
| 10003-2 | R wave duration in lead III |
| 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] |
| 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] |
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] |
| 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
| 100034-8 | Provider of automated external defibrillator use |
| 100035-5 | Exam finding location of Chest |
| 100036-3 | Exam finding location of Lung |
| 100037-1 | Patient contact disposition EMS unit |
| 100038-9 | Patient evaluation disposition EMS unit |
| 100039-7 | Crew disposition for patient care EMS unit |
| 10004-0 | R wave duration in lead V1 |
| 100040-5 | Patient transport disposition EMS unit |
| 100041-3 | Aminoglycoside [Susceptibility] |
| 100042-1 | Atovaquone [Susceptibility] |
| 100043-9 | Azithromycin+Ethambutol [Susceptibility] |
| 100044-7 | Cefcapene [Susceptibility] |
| 100045-4 | Cefozopran [Susceptibility] |
| 100046-2 | Cefquinome [Susceptibility] |
| 100047-0 | Cefteram [Susceptibility] |
| 100048-8 | Clarithromycin+Ethambutol [Susceptibility] |
| 100049-6 | Eravacycline [Susceptibility] |
| 10005-7 | R wave duration in lead V2 |
| 100050-4 | Erythromycin+Ethambutol [Susceptibility] |
| 100051-2 | Ethambutol+rifAMPin [Susceptibility] |
| 100052-0 | Flomoxef [Susceptibility] |
| 100053-8 | Fluoroquinolone [Susceptibility] |
| 100054-6 | Gamithromycin [Susceptibility] |
| 100055-3 | Optochin [Susceptibility] |
| 100056-1 | Panipenem [Susceptibility] |
| 100057-9 | Prothionamide [Susceptibility] |
| 100058-7 | Prulifloxacin [Susceptibility] |
| 100059-5 | Rifapentine [Susceptibility] |
| 10006-5 | R wave duration in lead V3 |
| 100060-3 | Tildipirosin [Susceptibility] |
| 100061-1 | Tosufloxacin [Susceptibility] |
| 100062-9 | Standard Dermatology Outcome Measures panel |
| 100063-7 | Primary skin concern |
| 100064-5 | Itch severity Reporting Period - Reported |
| 100065-2 | Satisfied with treatment |
| 100066-0 | Specular microscopy panel |
| 100067-8 | Eye Image magnification |
| 100068-6 | Right eye Fixation point [Angle] |
| 100069-4 | Left eye Fixation point [Angle] |
| 10007-3 | R wave duration in lead V4 |
| 100070-2 | Right cornea Cell density |
| 100071-0 | Left cornea Cell density |
| 100072-8 | Right cornea Coefficient of variation |
| 100073-6 | Left cornea Coefficient of variation |
| 100074-4 | Right cornea Hexagonality |
| 100075-1 | Left cornea Hexagonality |
| 100076-9 | Right cornea Endothelial cells counted |
| 100077-7 | Left cornea Endothelial cells counted |
| 100078-5 | Right cornea Endothelial cell area.min |
| 100079-3 | Left cornea Endothelial cell area.min |
| 10008-1 | R wave duration in lead V5 |
| 100080-1 | Right cornea Endothelial cell area.max |
| 100081-9 | Left cornea Endothelial cell area.max |
| 100082-7 | Right cornea Endothelial cell area.mean |
| 100083-5 | Left cornea Endothelial cell area.mean |
| 100084-3 | Right cornea Cell area.standard deviation |
| 100085-0 | Left cornea Cell area.standard deviation |
| 100086-8 | Right cornea Type of Analysis method by Specular microscopy |
| 100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
| 100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot |
| 100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
| 10009-9 | R wave duration in lead V6 |
| 100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
| 100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
| 100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
| 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
| 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
| 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
| 100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |
| 1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor |
| 10010-7 | R' wave amplitude in lead AVF |
| 100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
| 100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
| 100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
| 100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100105-6 | Filaria IgG and IgM panel - Serum |
| 100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay |
| 100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
| 100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot |
| 10011-5 | R' wave amplitude in lead AVL |
| 100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
| 100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot |
| 100113-0 | Helicobacter pylori Ab panel - Serum |
| 100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
| 100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
| 100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
| 100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
| 100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
| 100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
| 10012-3 | R' wave amplitude in lead AVR |
| 100120-5 | Chlamydia trachomatis Ab panel - Serum |
| 100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
| 100122-1 | Chlamydophila pneumoniae Ab panel - Serum |
| 100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
| 100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
| 100125-4 | Chlamydophila psittaci Ab panel - Serum |
| 100126-2 | Bordetella pertussis Ab.IgG panel - Serum |
| 100127-0 | Campylobacter sp Ab panel - Serum |
| 100128-8 | Cryptococcus sp Ag panel - Serum |
| 100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
| 10013-1 | R' wave amplitude in lead I |
| 100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |
| 100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
| 100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
| 100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
| 100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
| 100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
| 100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
| 100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
| 100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
| 100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
| 10014-9 | R' wave amplitude in lead II |
| 100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
| 100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
| 100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
| 100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
| 100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
| 100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
| 100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
| 100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
| 100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot |
| 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
| 10015-6 | R' wave amplitude in lead III |
| 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
| 100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
| 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100154-4 | Specimen collection supervision level |
| 100155-1 | Left cornea Type of Analysis method by Specular microscopy |
| 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
| 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
| 10016-4 | R' wave amplitude in lead V1 |
| 10017-2 | R' wave amplitude in lead V2 |
| 10018-0 | R' wave amplitude in lead V3 |
| 10019-8 | R' wave amplitude in lead V4 |
| 1002-5 | DBG Ab [Presence] in Serum or Plasma |
| 10020-6 | R' wave amplitude in lead V5 |
| 10021-4 | R' wave amplitude in lead V6 |
| 10022-2 | R' wave duration in lead AVF |
| 10023-0 | R' wave duration in lead AVL |
| 10024-8 | R' wave duration in lead AVR |
| 10025-5 | R' wave duration in lead I |
| 10026-3 | R' wave duration in lead II |
| 10027-1 | R' wave duration in lead III |
| 10028-9 | R' wave duration in lead V1 |
| 10029-7 | R' wave duration in lead V2 |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 10030-5 | R' wave duration in lead V3 |
| 10031-3 | R' wave duration in lead V4 |
| 10032-1 | R' wave duration in lead V5 |
| 10033-9 | R' wave duration in lead V6 |
| 10034-7 | S wave amplitude in lead AVF |
| 10035-4 | S wave amplitude in lead AVL |
| 10036-2 | S wave amplitude in lead AVR |
| 10037-0 | S wave amplitude in lead I |
| 10038-8 | S wave amplitude in lead II |
| 10039-6 | S wave amplitude in lead III |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 10040-4 | S wave amplitude in lead V1 |
| 10041-2 | S wave amplitude in lead V2 |
| 10042-0 | S wave amplitude in lead V3 |
| 10043-8 | S wave amplitude in lead V4 |
| 10044-6 | S wave amplitude in lead V5 |
| 10045-3 | S wave amplitude in lead V6 |
| 10046-1 | S wave duration in lead AVF |
| 10047-9 | S wave duration in lead AVL |
| 10048-7 | S wave duration in lead AVR |
| 10049-5 | S wave duration in lead I |
| 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
| 10050-3 | S wave duration in lead II |
| 10051-1 | S wave duration in lead III |
| 10052-9 | S wave duration in lead V1 |
| 10053-7 | S wave duration in lead V2 |
| 10054-5 | S wave duration in lead V3 |
| 10055-2 | S wave duration in lead V4 |
| 10056-0 | S wave duration in lead V5 |
| 10057-8 | S wave duration in lead V6 |
| 10058-6 | S' wave amplitude in lead AVF |
| 10059-4 | S' wave amplitude in lead AVL |
| 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
| 10060-2 | S' wave amplitude in lead AVR |
| 10061-0 | S' wave amplitude in lead I |
| 10062-8 | S' wave amplitude in lead II |
| 10063-6 | S' wave amplitude in lead III |
| 10064-4 | S' wave amplitude in lead V1 |
| 10065-1 | S' wave amplitude in lead V2 |
| 10066-9 | S' wave amplitude in lead V3 |
| 10067-7 | S' wave amplitude in lead V4 |
| 10068-5 | S' wave amplitude in lead V5 |
| 10069-3 | S' wave amplitude in lead V6 |
| 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
| 10070-1 | S' wave duration in lead AVF |
| 10071-9 | S' wave duration in lead AVL |
| 10072-7 | S' wave duration in lead AVR |
| 10073-5 | S' wave duration in lead I |
| 10074-3 | S' wave duration in lead II |
| 10075-0 | S' wave duration in lead III |
| 10076-8 | S' wave duration in lead V1 |
| 10077-6 | S' wave duration in lead V2 |
| 10078-4 | S' wave duration in lead V3 |
| 10079-2 | S' wave duration in lead V4 |
| 1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
| 10080-0 | S' wave duration in lead V5 |
| 10081-8 | S' wave duration in lead V6 |
| 10082-6 | ST initial amplitude 6 ms in lead AVF |
| 10083-4 | ST initial amplitude 6 ms in lead AVL |
| 10084-2 | ST initial amplitude 6 ms in lead AVR |
| 10085-9 | ST initial amplitude 6 ms in lead I |
| 10086-7 | ST initial amplitude 6 ms in lead II |
| 10087-5 | ST initial amplitude 6 ms in lead III |
| 10088-3 | ST initial amplitude 6 ms in lead V1 |
| 10089-1 | ST initial amplitude 6 ms in lead V2 |
| 1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
| 10090-9 | ST initial amplitude 6 ms in lead V3 |
| 10091-7 | ST initial amplitude 6 ms in lead V4 |
| 10092-5 | ST initial amplitude 6 ms in lead V5 |
| 10093-3 | ST initial amplitude 6 ms in lead V6 |
| 10094-1 | ST slope in lead AVF |
| 10095-8 | ST slope in lead AVL |
| 10096-6 | ST slope in lead AVR |
| 10097-4 | ST slope in lead I |
| 10098-2 | ST slope in lead II |
| 10099-0 | ST slope in lead III |
| 101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) |
| 1010-8 | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10100-6 | ST slope in lead V1 |
| 10101-4 | ST slope in lead V2 |
| 10102-2 | ST slope in lead V3 |
| 10103-0 | ST slope in lead V4 |
| 10104-8 | ST slope in lead V5 |
| 10105-5 | ST slope in lead V6 |
| 10106-3 | ST wave end displacement in lead AVF |
| 10107-1 | ST wave end displacement in lead AVL |
| 10108-9 | ST wave end displacement in lead AVR |
| 10109-7 | ST wave end displacement in lead I |
| 1011-6 | E sup(w) Ab [Presence] in Serum or Plasma from Donor |
| 10110-5 | ST wave end displacement in lead II |
| 10111-3 | ST wave end displacement in lead III |
| 10112-1 | ST wave end displacement in lead V1 |
| 10113-9 | ST wave end displacement in lead V2 |
| 10114-7 | ST wave end displacement in lead V3 |
| 10115-4 | ST wave end displacement in lead V4 |
| 10116-2 | ST wave end displacement in lead V5 |
| 10117-0 | ST wave end displacement in lead V6 |
| 10118-8 | ST wave mid displacement in lead AVF |
| 10119-6 | ST wave mid displacement in lead AVL |
| 1012-4 | E sup(w) Ab [Presence] in Serum or Plasma |
| 10120-4 | ST wave mid displacement in lead AVR |
| 10121-2 | ST wave mid displacement in lead I |
| 10122-0 | ST wave mid displacement in lead II |
| 10123-8 | ST wave mid displacement in lead III |
| 10124-6 | ST wave mid displacement in lead V1 |
| 10125-3 | ST wave mid displacement in lead V2 |
| 10126-1 | ST wave mid displacement in lead V3 |
| 10127-9 | ST wave mid displacement in lead V4 |
| 10128-7 | ST wave mid displacement in lead V5 |
| 10129-5 | ST wave mid displacement in lead V6 |
| 1013-2 | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10130-3 | T' wave amplitude in lead AVF |
| 10131-1 | T' wave amplitude in lead AVL |
| 10132-9 | T' wave amplitude in lead AVR |
| 10133-7 | T' wave amplitude in lead I |
| 10134-5 | T' wave amplitude in lead II |
| 10135-2 | T' wave amplitude in lead III |
| 10136-0 | T' wave amplitude in lead V1 |
| 10137-8 | T' wave amplitude in lead V2 |
| 10138-6 | T' wave amplitude in lead V3 |
| 10139-4 | T' wave amplitude in lead V4 |
| 1014-0 | E sup(w) Ag [Presence] on Red Blood Cells from Donor |
| 10140-2 | T' wave amplitude in lead V5 |
| 10141-0 | T' wave amplitude in lead V6 |
| 10142-8 | T wave amplitude in lead AVF |
| 10143-6 | T wave amplitude in lead AVL |
| 10144-4 | T wave amplitude in lead AVR |
| 10145-1 | T wave amplitude in lead I |
| 10146-9 | T wave amplitude in lead II |
| 10147-7 | T wave amplitude in lead III |
| 10148-5 | T wave amplitude in lead V1 |
| 10149-3 | T wave amplitude in lead V2 |
| 1015-7 | E sup(w) Ag [Presence] on Red Blood Cells |
| 10150-1 | T wave amplitude in lead V3 |
| 10151-9 | T wave amplitude in lead V4 |
| 10152-7 | T wave amplitude in lead V5 |
| 10153-5 | T wave amplitude in lead V6 |
| 10154-3 | Chief complaint Narrative - Reported |
| 10155-0 | History of allergies, reported |
| 10156-8 | History of Childhood diseases Narrative |
| 10157-6 | History of family member diseases Narrative |
| 10158-4 | History of Functional status Narrative |
| 10159-2 | History of Industrial exposure Narrative |
| 1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit |
| 10160-0 | History of Medication use Narrative |
| 10161-8 | History of Occupational exposure Narrative |
| 10162-6 | History of pregnancies Narrative |
| 10163-4 | History of pregnancies |
| 10164-2 | History of Present illness Narrative |
| 10165-9 | Deprecated History of psychiatric symptoms and diseases Narrative |
| 10166-7 | History of Social function Narrative |
| 10167-5 | History of Surgical procedures Narrative |
| 10168-3 | History of Cardiovascular system disorders Narrative |
| 10169-1 | History of Ear disorders Narrative |
| 1017-3 | E Ab [Presence] in Serum or Plasma from Donor |
| 10170-9 | History of Endocrine system disorders Narrative |
| 10171-7 | History of Eyes disorders Narrative |
| 10172-5 | History of Hematologic system disorders Narrative |
| 10173-3 | History of Musculoskeletal system disorders Narrative |
| 10174-1 | History of Nose disorders Narrative |
| 10175-8 | History of Oral cavity disorders Narrative |
| 10176-6 | History of Reproductive system disorders Narrative |
| 10177-4 | History of Respiratory system disorders Narrative |
| 10178-2 | History of Skin disorders Narrative |
| 10179-0 | History of Throat and Neck disorders Narrative |
| 1018-1 | E Ab [Presence] in Serum or Plasma |
| 10180-8 | History of Throat and Neck disorders |
| 10181-6 | History of Urinary tract disorders Narrative |
| 10182-4 | History of Travel Narrative |
| 10183-2 | Hospital discharge medications Narrative |
| 10184-0 | Hospital discharge physical findings Narrative |
| 10185-7 | Hospital discharge procedures Narrative |
| 10186-5 | Identifying information Narrative Observed |
| 10187-3 | Review of systems Narrative - Reported |
| 10188-1 | Review of systems overview Narrative - Reported |
| 10189-9 | Review of systems overview - Reported |
| 1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit |
| 10190-7 | Mental status Narrative |
| 10191-5 | Physical findings of Abdomen Narrative |
| 10192-3 | Physical findings of Back Narrative |
| 10193-1 | Physical findings of Breasts Narrative |
| 10194-9 | Physical findings of Neurologic deep tendon reflexes Narrative |
| 10195-6 | Physical findings of Ear Narrative |
| 10196-4 | Physical findings of Extremities Narrative |
| 10197-2 | Physical findings of Eye Narrative |
| 10198-0 | Physical findings of Genitourinary tract Narrative |
| 10199-8 | Physical findings of Head Narrative |
| 102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer |
| 1020-7 | E Ag [Presence] on Red Blood Cells from Donor |
| 10200-4 | Physical findings of Heart Narrative |
| 10201-2 | Physical findings of Mouth and Throat and Teeth Narrative |
| 10202-0 | Physical findings of Nervous system Narrative |
| 10203-8 | Physical findings of Nose Narrative |
| 10204-6 | Physical findings of Pelvis Narrative |
| 10205-3 | Physical findings of Rectum Narrative |
| 10206-1 | Physical findings of Skin Narrative |
| 10207-9 | Physical findings of Thorax and Lungs Narrative |
| 10208-7 | Physical findings of Vessels Narrative |
| 10209-5 | Physical findings of Neurologic balance and Coordination Narrative |
| 1021-5 | E Ag [Presence] on Red Blood Cells |
| 10210-3 | Physical findings of General status Narrative |
| 10211-1 | Physical findings of Sense of touch Narrative |
| 10212-9 | Physical findings of Strength Narrative |
| 10213-7 | Surgical operation note anesthesia Narrative |
| 10214-5 | Surgical operation note anesthesia duration |
| 10215-2 | Surgical operation note findings Narrative |
| 10216-0 | Surgical operation note fluids Narrative |
| 10217-8 | Surgical operation note indications [Interpretation] Narrative |
| 10218-6 | Surgical operation note postoperative diagnosis Narrative |
| 10219-4 | Surgical operation note preoperative diagnosis Narrative |
| 1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10220-2 | Surgical operation note prep time duration |
| 10221-0 | Surgical operation note specimens taken Narrative |
| 10222-8 | Surgical operation note surgical complications [Interpretation] Narrative |
| 10223-6 | Surgical operation note surgical procedure Narrative |
| 10224-4 | Hemodynamic method special circumstances |
| 10225-1 | Cardiac measurement device Institution inventory number |
| 10226-9 | Oxygen content in Intravascular space |
| 10227-7 | Cardiac measurement device Vendor model number |
| 10228-5 | Cardiac measurement device Vendor serial number |
| 10229-3 | Hemodynamic method Type of |
| 1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 10230-1 | Left ventricular Ejection fraction |
| 10231-9 | Right ventricular Ejection fraction |
| 10232-7 | Oxygen content in Aorta root |
| 10233-5 | Oxygen content in Left atrium |
| 10234-3 | Oxygen content in Right atrium |
| 10235-0 | Oxygen content in High right atrium |
| 10236-8 | Oxygen content in Low right atrium |
| 10237-6 | Oxygen content in Mid right atrium |
| 10238-4 | Oxygen content in Left ventricle |
| 10239-2 | Oxygen content in Right ventricular outflow tract |
| 1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma |
| 10240-0 | Oxygen content in Right ventricle |
| 10241-8 | Oxygen content in Coronary sinus |
| 10242-6 | Oxygen content in Ductus arteriosus |
| 10243-4 | Oxygen content in Inferior vena cava |
| 10244-2 | Oxygen content in Left pulmonary artery |
| 10245-9 | Oxygen content in Main pulmonary artery |
| 10246-7 | Oxygen content in Right pulmonary artery |
| 10247-5 | Oxygen content in Pulmonary wedge |
| 10248-3 | Oxygen content in Superior vena cava |
| 10249-1 | Heart rate device Institution inventory number |
| 1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10250-9 | Heart rate device Vendor model number |
| 10251-7 | Heart rate device Vendor serial number |
| 10252-5 | Biliary drain site |
| 10253-3 | Type of Biliary drain |
| 10254-1 | Type of Peritoneal drain |
| 10255-8 | Type of Subarachnoid drain |
| 10256-6 | Biliary drain Institution inventory number |
| 10257-4 | Chest tube Institution inventory number |
| 10258-2 | Enteral tube Institution inventory number |
| 10259-0 | Gastrostomy tube Institution inventory number |
| 1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 10260-8 | GI tube Institution inventory number |
| 10261-6 | Intravascular tube Institution inventory number |
| 10262-4 | IO tube Institution inventory number |
| 10263-2 | Nasogastric tube Institution inventory number |
| 10264-0 | Oral tube Institution inventory number |
| 10265-7 | Peritoneal drain Institution inventory number |
| 10266-5 | Peritoneal tube Institution inventory number |
| 10267-3 | Rate control device Institution inventory number |
| 10268-1 | Stool collection device Institution inventory number |
| 10269-9 | Subarachnoid drain Institution inventory number |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
| 10270-7 | Synovial drain Institution inventory number |
| 10271-5 | Tube or drain Institution inventory number |
| 10272-3 | Upper GI tube Institution inventory number |
| 10273-1 | Bladder irrigation tube Institution inventory number |
| 10274-9 | Urine tube Institution inventory number |
| 10275-6 | Wound drain device Institution inventory number |
| 10276-4 | Peritoneal drain site |
| 10277-2 | Stool collection site |
| 10278-0 | Subarachnoid drain site |
| 10279-8 | Biliary drain Vendor model number |
| 1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10280-6 | Chest tube Vendor model number |
| 10281-4 | Enteral tube Vendor model number |
| 10282-2 | Gastrostomy tube Vendor model number |
| 10283-0 | GI tube Vendor model number |
| 10284-8 | Intravascular tube Vendor model number |
| 10285-5 | IO tube Vendor model number |
| 10286-3 | Nasogastric tube Vendor model number |
| 10287-1 | Oral tube Vendor model number |
| 10288-9 | Peritoneal drain Vendor model number |
| 10289-7 | Peritoneal tube Vendor model number |
| 1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 10290-5 | Rate control device Vendor model number |
| 10291-3 | Stool collection device Vendor model number |
| 10292-1 | Subarachnoid drain Vendor model number |
| 10293-9 | Synovial drain Vendor model number |
| 10294-7 | Tube or drain Vendor model number |
| 10295-4 | Upper GI tube Vendor model number |
| 10296-2 | Bladder irrigation tube Vendor model number |
| 10297-0 | Urine tube Vendor model number |
| 10298-8 | Wound drain device Vendor model number |
| 10299-6 | Biliary drain Vendor serial number |
| 103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
| 1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma |
| 10300-2 | Chest tube Vendor serial number |
| 10301-0 | Enteral tube Vendor serial number |
| 10302-8 | Gastrostomy tube Vendor serial number |
| 10303-6 | GI tube Vendor serial number |
| 10304-4 | Intravascular tube Vendor serial number |
| 10305-1 | IO tube Vendor serial number |
| 10306-9 | Nasogastric tube Vendor serial number |
| 10307-7 | Oral tube Vendor serial number |
| 10308-5 | Peritoneal drain Vendor serial number |
| 10309-3 | Peritoneal tube Vendor serial number |
| 1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10310-1 | Rate control device Vendor serial number |
| 10311-9 | Stool collection device Vendor serial number |
| 10312-7 | Subarachnoid drain Vendor serial number |
| 10313-5 | Synovial drain Vendor serial number |
| 10314-3 | Tube or drain Vendor serial number |
| 10315-0 | Upper GI tube Vendor serial number |
| 10316-8 | Bladder irrigation tube Vendor serial number |
| 10317-6 | Urine tube Vendor serial number |
| 10318-4 | Wound drain device Vendor serial number |
| 10319-2 | Enema device Institution inventory number |
| 1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor |
| 10320-0 | Enema device Vendor model number |
| 10321-8 | Enema device Vendor serial number |
| 10322-6 | Potassium intake 24 hour |
| 10323-4 | Wound drain fluid [Appearance] Lower GI tract |
| 10324-2 | Breath rate device Institution inventory number |
| 10325-9 | Breath rate device Vendor model number |
| 10326-7 | Breath rate device Vendor serial number |
| 10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count |
| 10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
| 10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count |
| 10331-7 | Rh [Type] in Blood |
| 10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 10333-3 | Appearance of Cerebral spinal fluid |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 10335-8 | Color of Cerebral spinal fluid |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
| 10337-4 | Procollagen type I [Mass/volume] in Serum |
| 10338-2 | Barbiturates [Mass/volume] in Serum or Plasma |
| 10339-0 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
| 1034-8 | Fetal cell screen [Interpretation] in Blood |
| 10340-8 | Molindone [Mass/volume] in Serum or Plasma |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma |
| 10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
| 10343-2 | Temazepam [Mass/volume] in Serum or Plasma |
| 10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma |
| 10345-7 | Trihexyphenidyl [Mass/volume] in Urine |
| 10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis |
| 10347-3 | Babesia microti identified in Blood by Light microscopy |
| 10348-1 | Bordetella parapertussis Ab [Presence] in Serum |
| 10349-9 | Brucella sp Ab [Units/volume] in Serum |
| 1035-5 | Fresh frozen plasma given [Volume] |
| 10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
| 10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
| 10353-1 | Bacteria identified in Nose by Aerobe culture |
| 10354-9 | Bacteria identified in Urethra by Culture |
| 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
| 10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain |
| 10357-2 | Microscopic observation [Identifier] in Wound by Gram stain |
| 10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
| 10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum |
| 1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum |
| 10362-2 | Endomysium IgA Ab [Presence] in Serum |
| 10363-0 | Barbiturates [Presence] in Specimen |
| 10364-8 | Cotinine [Mass/mass] in Hair |
| 10365-5 | Cotinine [Mass/volume] in Serum or Plasma |
| 10366-3 | Cotinine [Mass/volume] in Urine |
| 10367-1 | Ethanol [Mass/volume] in Gastric fluid |
| 10368-9 | Lead [Mass/volume] in Capillary blood |
| 10369-7 | Opiates [Mass/mass] in Hair |
| 1037-1 | G Ab [Presence] in Serum or Plasma from Donor |
| 10370-5 | Phencyclidine [Mass/mass] in Hair |
| 10371-3 | Bite cells [Presence] in Blood by Light microscopy |
| 10372-1 | Blister cells [Presence] in Blood by Light microscopy |
| 10373-9 | Fragments [Presence] in Blood by Light microscopy |
| 10374-7 | Helmet cells [Presence] in Blood by Light microscopy |
| 10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy |
| 10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy |
| 10377-0 | Pencil cells [Presence] in Blood by Light microscopy |
| 10378-8 | Polychromasia [Presence] in Blood by Light microscopy |
| 10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy |
| 1038-9 | G Ab [Presence] in Serum or Plasma |
| 10380-4 | Stomatocytes [Presence] in Blood by Light microscopy |
| 10381-2 | Target cells [Presence] in Blood by Light microscopy |
| 10382-0 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 10383-8 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor |
| 10384-6 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells |
| 10385-3 | Albumin concentration given |
| 10386-1 | Albumin given [Volume] |
| 10387-9 | Autologous erythrocytes given [Volume] |
| 10388-7 | Autologous whole blood given [Volume] |
| 10389-5 | Blood product.other [Type] |
| 1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit |
| 10390-3 | Blood product special preparation [Type] |
| 10391-1 | Cytomegalovirus immune globulin given [Volume] |
| 10392-9 | Cryoprecipitate given [Volume] |
| 10393-7 | Factor IX given [Type] |
| 10394-5 | Factor IX given [Volume] |
| 10395-2 | Factor VIII given [Type] |
| 10396-0 | Factor VIII given [Volume] |
| 10397-8 | Hepatitis B immune globulin given [Volume] |
| 10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit |
| 10399-4 | I Ag [Presence] on Red Blood Cells from Donor |
| 104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1040-5 | G Ag [Presence] on Red Blood Cells from Donor |
| 10400-0 | I Ag [Presence] on Red Blood Cells |
| 10401-8 | Immune serum globulin given [Type] |
| 10402-6 | Immune serum globulin given [Volume] |
| 10403-4 | Inject immune serum globulin [Volume] |
| 10404-2 | Inject Rh immune globulin [Volume] |
| 10405-9 | Inject varicella zoster virus immune globulin [Volume] |
| 10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit |
| 10407-5 | little i Ag [Presence] on Red Blood Cells from Donor |
| 10408-3 | little i Ag [Presence] on Red Blood Cells |
| 10409-1 | Pentaspan given [Volume] |
| 1041-3 | G Ag [Presence] on Red Blood Cells |
| 10410-9 | Plasma given [Type] |
| 10411-7 | Plasma given [Volume] |
| 10412-5 | Platelets given [Type] |
| 10413-3 | Rh immune globulin given [Volume] |
| 10414-1 | Transfuse albumin [Volume] |
| 10415-8 | Transfuse blood exchange transfusion [Volume] |
| 10416-6 | Transfuse blood product other [Volume] |
| 10417-4 | Transfuse cryoprecipitate [Volume] |
| 10418-2 | Transfuse factor IX [Volume] |
| 10419-0 | Transfuse factor VIII [Volume] |
| 1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit |
| 10420-8 | Transfuse immune serum globulin [Volume] |
| 10421-6 | Transfuse Pentaspan [Volume] |
| 10422-4 | Transfuse plasma [Volume] |
| 10423-2 | Transfuse platelets [Volume] |
| 10424-0 | Transfuse erythrocytes [Volume] |
| 10425-7 | Transfuse Rh immune globulin [Volume] |
| 10426-5 | Transfuse whole blood [Volume] |
| 10427-3 | Transfuse whole blood autologous [Volume] |
| 10428-1 | Varicella zoster virus immune globulin given [Volume] |
| 10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain |
| 1043-9 | H Ab [Presence] in Serum or Plasma from Donor |
| 10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain |
| 10431-5 | B-cell Ag [Presence] in Tissue by Immune stain |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
| 10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain |
| 10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain |
| 10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain |
| 10436-4 | CD15 Ag [Presence] in Tissue by Immune stain |
| 10437-2 | CD16 Ag [Presence] in Tissue by Immune stain |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
| 10439-8 | CD3 Ag [Presence] in Tissue by Immune stain |
| 1044-7 | H Ab [Presence] in Serum |
| 10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain |
| 10441-4 | CD34 Ag [Presence] in Tissue by Immune stain |
| 10442-2 | CD56 Ag [Presence] in Tissue by Immune stain |
| 10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
| 10444-8 | CD57 Ag [Presence] in Tissue by Immune stain |
| 10445-5 | CD11c Ag [Presence] in Tissue by Immune stain |
| 10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain |
| 10447-1 | M-5 Ag [Presence] in Tissue by Immune stain |
| 10448-9 | T-cell Ag [Presence] in Tissue by Immune stain |
| 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
| 1045-4 | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
| 10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
| 10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
| 10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
| 10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
| 10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
| 10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
| 10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
| 10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
| 1046-2 | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor |
| 10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
| 10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
| 10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
| 10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
| 10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
| 10466-1 | Anion gap 3 in Serum or Plasma |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
| 10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
| 1047-0 | Deprecated H NOS Ab [Presence] in Serum or Plasma |
| 10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
| 10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
| 10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
| 10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
| 10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
| 10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
| 10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
| 10479-4 | CD227 Ag [Presence] in Tissue by Immune stain |
| 1048-8 | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
| 10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
| 10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
| 10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
| 10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
| 10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
| 10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
| 10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
| 10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
| 1049-6 | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor |
| 10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
| 10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
| 10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
| 10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
| 10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain |
| 10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
| 10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
| 10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain |
| 105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) |
| 1050-4 | Deprecated H NOS Ag [Presence] on Red Blood Cells |
| 10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma |
| 10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
| 10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
| 10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
| 10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
| 10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
| 10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
| 10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
| 1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood |
| 10510-6 | S-100 Ag [Presence] in Tissue by Immune stain |
| 10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
| 10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
| 10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
| 10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
| 10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
| 10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
| 10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
| 10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
| 10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
| 1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |
| 10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
| 10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
| 10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
| 10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
| 10525-4 | Microscopic observation [Identifier] in Specimen by Cyto stain |
| 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
| 10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
| 10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma |
| 10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
| 1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor |
| 10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma |
| 10531-2 | Bretylium [Mass/volume] in Serum or Plasma |
| 10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma |
| 10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma |
| 10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
| 10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
| 10539-5 | glipiZIDE [Mass/volume] in Serum or Plasma |
| 1054-6 | Deprecated I (intermediate) subtype [Presence] in srum |
| 10540-3 | glyBURIDE [Mass/volume] in Serum or Plasma |
| 10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma |
| 10542-9 | Metharbital [Mass/volume] in Serum or Plasma |
| 10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma |
| 10547-8 | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma |
| 10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma |
| 10549-4 | Pirmenol [Mass/volume] in Serum or Plasma |
| 1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
| 10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma |
| 10551-0 | Triamterene [Mass/volume] in Serum or Plasma |
| 10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
| 10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
| 10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma |
| 10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa |
| 10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma |
| 10557-7 | Adenosine triphosphate [Moles/volume] in Semen |
| 10558-5 | Albumin [Moles/volume] in Semen |
| 10559-3 | Deprecated Calcium [Molecules/volume] in Semen |
| 1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
| 10561-9 | Carnitine [Moles/volume] in Semen |
| 10562-7 | Cells [#/volume] in Cervical mucus |
| 10563-5 | Cells other than spermatozoa [#/volume] in Semen |
| 10564-3 | Cervical mucus [Volume] |
| 10565-0 | Choriogonadotropin [Units/volume] in Semen |
| 10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen |
| 10567-6 | Citrate [Moles/volume] in Semen |
| 10568-4 | Clarity of Semen |
| 10569-2 | Color of Semen |
| 1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells |
| 10570-0 | Consistency of Cervical mucus |
| 10571-8 | Deprecated Consistency of Semen |
| 10572-6 | Deprecated Duration^post ejaculation |
| 10573-4 | Ferning [Type] in Cervical mucus |
| 10574-2 | Fructose [Moles/volume] in Semen |
| 10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
| 10576-7 | Germ cells.immature [#/volume] in Semen |
| 10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
| 10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma |
| 10579-1 | Leukocytes [#/volume] in Semen |
| 1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit |
| 10580-9 | Liquefaction [Time] in Semen |
| 10581-7 | Deprecated Number of entities [#] in Spermatozoa |
| 10582-5 | pH of Cervical mucus |
| 10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen |
| 10584-1 | Deprecated Protein [Mass/volume] in Semen |
| 10585-8 | Round cells [#/volume] in Semen |
| 10586-6 | Deprecated Volume of Semen |
| 10587-4 | Sexual abstinence duration |
| 10588-2 | Spermatogonia [#/volume] in Semen |
| 10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
| 1059-5 | I Ab [Presence] in Serum or Plasma from Donor |
| 10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
| 10591-6 | Primary Spermatocytes [#/volume] in Semen |
| 10592-4 | Secondary Spermatocytes [#/volume] in Semen |
| 10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen |
| 10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen |
| 10595-7 | Deprecated Spermatozoa [#/volume] in Semen |
| 10596-5 | Deprecated Spermatozoa Ab in cervical mucosa |
| 10597-3 | Deprecated Spermatozoa Ab in semen |
| 10598-1 | Deprecated Spermatozoa Ab in serum |
| 10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
| 106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer |
| 1060-3 | I Ab [Presence] in Serum or Plasma |
| 10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
| 10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
| 10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
| 10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
| 10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
| 10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen |
| 10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen |
| 10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen |
| 10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
| 10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen |
| 1061-1 | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
| 10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen |
| 10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen |
| 10613-8 | Spermatozoa Viable/100 spermatozoa in Semen |
| 10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 1062-9 | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor |
| 10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
| 10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen |
| 10622-9 | Spermatozoa Normal/100 spermatozoa in Semen |
| 10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen |
| 10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen |
| 10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen |
| 10626-0 | Spermatozoa Slow/100 spermatozoa in Semen |
| 10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen |
| 10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen |
| 10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
| 1063-7 | Deprecated I NOS Ab [Presence] in Serum or Plasma |
| 10630-2 | Spinnbarkeit [Length] in Cervical mucus |
| 10631-0 | Testosterone [Moles/volume] in Semen |
| 10632-8 | Time until next menstrual period |
| 10633-6 | Zinc [Moles/volume] in Semen |
| 10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture |
| 10636-9 | Acanthamoeba sp identified in Eye by Wet preparation |
| 10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain |
| 10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture |
| 10639-3 | Thermophilic Actinomycetes identified in Specimen by Organism specific culture |
| 1064-5 | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |
| 10641-9 | Amoeba identified in Aspirate by Immune stain |
| 10642-7 | Amoeba identified in Aspirate by Wet preparation |
| 10643-5 | Amoeba identified in Stool by Organism specific culture |
| 10644-3 | Arthropod identified in Specimen |
| 10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
| 10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy |
| 10647-6 | Babesia sp identified in Blood by Thick film |
| 10648-4 | Babesia sp identified in Blood by Thin film |
| 10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy |
| 1065-2 | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor |
| 10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification |
| 10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
| 10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
| 10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain |
| 10656-7 | Coccidia identified in Stool by Acid fast stain |
| 10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence |
| 10658-3 | Cyanobacterium identified in Water by Light microscopy |
| 10659-1 | Cyclospora sp identified in Stool by Acid fast stain |
| 1066-0 | Deprecated I NOS Ag [Presence] on Red Blood Cells |
| 10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
| 10661-7 | Dinoflagellate identified in Water by Light microscopy |
| 10662-5 | Filaria identified in Blood by Concentration |
| 10663-3 | Filaria identified in Blood by Thick film |
| 10664-1 | Filaria identified in Blood by Thin film |
| 10665-8 | Fungus colony count [#/volume] in Specimen by Environmental culture |
| 10666-6 | Fungus identified in Tissue by Fontana-Masson stain |
| 10667-4 | Fungus identified in Specimen by Animal inoculation |
| 10668-2 | Fungus identified in Specimen by Environmental culture |
| 10669-0 | Fungus identified in Specimen by Sticky tape for environmental fungus |
| 1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture |
| 10671-6 | Helminth identified in Specimen |
| 10672-4 | Helminth+Arthropod identified in Specimen |
| 10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
| 10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
| 10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
| 10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
| 10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
| 10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
| 1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor |
| 10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
| 10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy |
| 10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification |
| 10683-1 | Hydatid cyst identified in Aspirate by Immune stain |
| 10684-9 | Hydatid cyst identified in Liver by Wet preparation |
| 10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation |
| 10686-4 | Leishmania sp identified in Tissue by Giemsa stain |
| 10687-2 | Leishmania sp identified in Tissue by Organism specific culture |
| 10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation |
| 10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation |
| 1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma |
| 10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified |
| 10691-4 | Mushroom.toxic identified by Inspection |
| 10692-2 | Mushroom.toxic identified in Food by Light microscopy |
| 10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation |
| 10696-3 | Norovirus [Identifier] in Stool by Electron microscopy |
| 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
| 10699-7 | Onchocerca sp identified in Tissue by Wet preparation |
| 107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy |
| 10701-1 | Ova and parasites identified in Stool by Concentration |
| 10702-9 | Ova and parasites identified in Stool by Immune stain |
| 10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
| 10704-5 | Ova and parasites identified in Stool by Light microscopy |
| 10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain |
| 10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy |
| 10707-8 | Toxic Plant identified in Plant specimen by Inspection |
| 10708-6 | Toxic Plant identified in Vomitus by Light microscopy |
| 10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
| 1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor |
| 10710-2 | Plasmodium sp identified in Blood by Thin film |
| 10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
| 10712-8 | Pneumocystis sp identified in Lung tissue |
| 10713-6 | Prototheca identified in Specimen by Culture |
| 10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy |
| 10716-9 | Schistosoma sp identified in Specimen by Organism specific culture |
| 10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
| 10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
| 10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot |
| 1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells |
| 10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
| 10722-7 | Torovirus [Identifier] in Stool by Electron microscopy |
| 10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
| 10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
| 10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
| 10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
| 10727-6 | Toxoplasma gondii identified in Tissue |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
| 10729-2 | Trypanosoma sp identified in Blood by Light microscopy |
| 1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10730-0 | Trypanosoma sp identified in Blood by Organism specific culture |
| 10731-8 | Trypanosoma sp identified in Blood by Thick film |
| 10732-6 | Trypanosoma sp identified in Blood by Thin film |
| 10733-4 | Trypanosoma sp identified in Blood by Wet preparation |
| 10734-2 | Varicella zoster virus identified in Skin by Electron microscopy |
| 10735-9 | Viral sequencing [Identifier] in Serum by Sequencing |
| 10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy |
| 10737-5 | Virus identified in Stool by Electron microscopy |
| 10738-3 | Virus identified in Tissue by Electron microscopy |
| 10739-1 | Virus identified in Specimen by Electron microscopy |
| 1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor |
| 10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
| 10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
| 10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
| 10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
| 10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
| 10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
| 10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
| 10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
| 10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
| 10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
| 1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma |
| 10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
| 10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
| 10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
| 10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
| 10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
| 10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
| 10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |